Secular Trends in Opportunistic Infections, Cancers and Mortality in Patients With Aids During the Era of Modern Combination Antiretroviral Therapy

dc.contributor.author Sezgin, Efe
dc.contributor.author Van Natta, Mark L.
dc.contributor.author Thorne, Jennifer E.
dc.contributor.author Puhan, M. A.
dc.contributor.author Jabs, D. A.
dc.coverage.doi 10.1111/hiv.12609
dc.date.accessioned 2020-01-17T08:59:47Z
dc.date.available 2020-01-17T08:59:47Z
dc.date.issued 2018
dc.description.abstract Objectives: The aim of the study was to estimate the incidence of, determine risk factors for, and investigate the consequences of opportunistic infections (OIs) and malignancies among patients with the acquired immune deficiency syndrome (AIDS) in the era of modern combination antiretroviral therapy (cART). Methods: Three enrolment periods (1998–2002, 2003–2005 and 2006–2012), corresponding to changes in predominant cART regimens, were compared among 1889 participants enrolled in a prospective cohort study, the Longitudinal Study of Ocular Complications of AIDS (LSOCA). Incidences of AIDS-related OIs and cancers were estimated. Multivariate logistic and Cox regression models were used to determine the effect of demographic and clinical characteristics on OIs and mortality. Results: Between participants enrolled in the 1998–2002 and 2006–2012 enrolment periods, the incidence of OIs decreased from 27 per 1000 person-years (PY) to 11 per 1000 PY (P < 0.001), and mortality decreased from 41 per 1000 PY to 18 per 1000 PY (P < 0.0001), corresponding to improvements in cART regimens. Conclusions: Improvements in cART regimens led to a progressive decline in the incidence of OIs and mortality between 1999 and 2013 among patients with AIDS in the era of modern cART. en_US
dc.description.sponsorship National Eye Institute, the National Institutes of Health, Bethesda, MD (U10 EY 08052); Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD (U10 EY 08057); University of Wisconsin, Madison School of Medicine, Madison, WI (U10 EY 08067); Johns Hopkins Center for AIDS Research grant from the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, Bethesda, MD, USA (1P30AI094189); TUBITAK (116C090) en_US
dc.identifier.citation Sezgin, E., Van Natta, M. L., Thorne, J. E., Puhan, M. A., and Jabs, D. A. (2018). Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy. HIV Medicine, 19(6), 411-419. doi:10.1111/hiv.12609 en_US
dc.identifier.doi 10.1111/hiv.12609 en_US
dc.identifier.doi 10.1111/hiv.12609
dc.identifier.issn 1464-2662
dc.identifier.scopus 2-s2.0-85044314262
dc.identifier.uri https://doi.org/10.1111/hiv.12609
dc.identifier.uri https://hdl.handle.net/11147/7598
dc.language.iso en en_US
dc.publisher John Wiley and Sons Inc. en_US
dc.relation.ispartof HIV Medicine en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject AIDS en_US
dc.subject Opportunistic infection en_US
dc.subject Antiretroviral therapy en_US
dc.subject Integrase inhibitor en_US
dc.subject AIDS related complex en_US
dc.subject Mortality rate en_US
dc.title Secular Trends in Opportunistic Infections, Cancers and Mortality in Patients With Aids During the Era of Modern Combination Antiretroviral Therapy en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id 0000-0002-8000-7485
gdc.author.institutional Sezgin, Efe
gdc.bip.impulseclass C4
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology. Food Engineering en_US
gdc.description.endpage 419 en_US
gdc.description.issue 6 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 411 en_US
gdc.description.volume 19 en_US
gdc.description.wosquality Q2
gdc.identifier.openalex W2792958190
gdc.identifier.pmid 29573311
gdc.identifier.wos WOS:000435938300007
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.accesstype BRONZE
gdc.oaire.diamondjournal false
gdc.oaire.downloads 0
gdc.oaire.impulse 12.0
gdc.oaire.influence 3.474972E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Adult
gdc.oaire.keywords Male
gdc.oaire.keywords opportunistic infection
gdc.oaire.keywords AIDS-related cancer
gdc.oaire.keywords 610 Medicine & health
gdc.oaire.keywords Opportunistic infection
gdc.oaire.keywords Risk Factors
gdc.oaire.keywords Antiretroviral Therapy, Highly Active
gdc.oaire.keywords Neoplasms
gdc.oaire.keywords 2736 Pharmacology (medical)
gdc.oaire.keywords Humans
gdc.oaire.keywords Longitudinal Studies
gdc.oaire.keywords Prospective Studies
gdc.oaire.keywords Integrase inhibitor
gdc.oaire.keywords AIDS related complex
gdc.oaire.keywords Acquired Immunodeficiency Syndrome
gdc.oaire.keywords AIDS-Related Opportunistic Infections
gdc.oaire.keywords HIV
gdc.oaire.keywords 10060 Epidemiology, Biostatistics and Prevention Institute (EBPI)
gdc.oaire.keywords 2725 Infectious Diseases
gdc.oaire.keywords Middle Aged
gdc.oaire.keywords 2719 Health Policy
gdc.oaire.keywords mortality
gdc.oaire.keywords Mortality rate
gdc.oaire.keywords Antiretroviral therapy
gdc.oaire.keywords CD4 Lymphocyte Count
gdc.oaire.keywords AIDS
gdc.oaire.keywords Population Surveillance
gdc.oaire.keywords Drug Therapy, Combination
gdc.oaire.keywords Female
gdc.oaire.popularity 9.238275E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.oaire.views 6
gdc.openalex.collaboration International
gdc.openalex.fwci 2.44389994
gdc.openalex.normalizedpercentile 0.86
gdc.opencitations.count 16
gdc.plumx.crossrefcites 15
gdc.plumx.mendeley 34
gdc.plumx.pubmedcites 8
gdc.plumx.scopuscites 16
gdc.scopus.citedcount 16
gdc.wos.citedcount 16
relation.isAuthorOfPublication.latestForDiscovery 77721b7d-10bb-4a8e-8cd8-10a1088bfb1b
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4019-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
hiv.12609.pdf
Size:
244.17 KB
Format:
Adobe Portable Document Format
Description:
Makale (Article)

License bundle

Now showing 1 - 1 of 1
Loading...
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: